MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer

Yi Chen, Mohd Saif Zaman, Guoren Deng, Shahana Majid, Shranjot Saini, Jan Liu, Yuichiro Tanaka, Rajvir Dahiya

Research output: Contribution to journalArticle

Abstract

ARHI is an imprinted tumor suppressor gene and is downregulated in various malignancies. However, ARHI expression, function, and mechanisms of action in prostate cancer have not been reported. Here, we report that ARHI mRNA and protein levels were downregulated in prostate cancer tissues compared with adjacent normal tissues. Overexpression of ARHI inhibited cell proliferation, colony formation, invasion, and induced apoptosis. Further studies on a new mechanism of ARHI downregulation showed a significant inverse relationship between ARHI and miR-221 and 222, which were upregulated in prostate cancer cell lines. Transfection of miR-221 and 222 inhibitors into PC-3 cells caused a significant induction of ARHI expression. A direct interaction of miR-221 or 222 with a target site on the 3′UTR of ARHI was confirmed by a dual luciferase pMIR-REPORT assay. Finally, we also found that genistein upregulates ARHI by downregulating miR-221 and 222 in PC-3 cells. In conclusion, ARHI is a tumor suppressor gene downregulated in prostate cancer, and overexpression of ARHI can inhibit cell proliferation, colony formation, and invasion. This study demonstrates for the first time that prostate cancer cells have decreased level of ARHI which could be caused by direct targeting of 3′UTR of ARHI by miR221/222. Genistein, a potential nontoxic chemopreventive agent, restores expression of ARHI and may be an important dietary therapeutic agent for treating prostate cancer.

Original languageEnglish (US)
Pages (from-to)76-86
Number of pages11
JournalCancer Prevention Research
Volume4
Issue number1
DOIs
StatePublished - Jan 1 2011
Externally publishedYes

Fingerprint

Genistein
Tumor Suppressor Genes
MicroRNAs
Prostatic Neoplasms
Down-Regulation
Cell Proliferation
Luciferases
Transfection
Up-Regulation
Apoptosis
Cell Line
Messenger RNA
Neoplasms
Proteins

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. / Chen, Yi; Saif Zaman, Mohd; Deng, Guoren; Majid, Shahana; Saini, Shranjot; Liu, Jan; Tanaka, Yuichiro; Dahiya, Rajvir.

In: Cancer Prevention Research, Vol. 4, No. 1, 01.01.2011, p. 76-86.

Research output: Contribution to journalArticle

Chen, Y, Saif Zaman, M, Deng, G, Majid, S, Saini, S, Liu, J, Tanaka, Y & Dahiya, R 2011, 'MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer', Cancer Prevention Research, vol. 4, no. 1, pp. 76-86. https://doi.org/10.1158/1940-6207.CAPR-10-0167
Chen, Yi ; Saif Zaman, Mohd ; Deng, Guoren ; Majid, Shahana ; Saini, Shranjot ; Liu, Jan ; Tanaka, Yuichiro ; Dahiya, Rajvir. / MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. In: Cancer Prevention Research. 2011 ; Vol. 4, No. 1. pp. 76-86.
@article{8b49b7a14fa845f2aa3294b05a6884d0,
title = "MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer",
abstract = "ARHI is an imprinted tumor suppressor gene and is downregulated in various malignancies. However, ARHI expression, function, and mechanisms of action in prostate cancer have not been reported. Here, we report that ARHI mRNA and protein levels were downregulated in prostate cancer tissues compared with adjacent normal tissues. Overexpression of ARHI inhibited cell proliferation, colony formation, invasion, and induced apoptosis. Further studies on a new mechanism of ARHI downregulation showed a significant inverse relationship between ARHI and miR-221 and 222, which were upregulated in prostate cancer cell lines. Transfection of miR-221 and 222 inhibitors into PC-3 cells caused a significant induction of ARHI expression. A direct interaction of miR-221 or 222 with a target site on the 3′UTR of ARHI was confirmed by a dual luciferase pMIR-REPORT assay. Finally, we also found that genistein upregulates ARHI by downregulating miR-221 and 222 in PC-3 cells. In conclusion, ARHI is a tumor suppressor gene downregulated in prostate cancer, and overexpression of ARHI can inhibit cell proliferation, colony formation, and invasion. This study demonstrates for the first time that prostate cancer cells have decreased level of ARHI which could be caused by direct targeting of 3′UTR of ARHI by miR221/222. Genistein, a potential nontoxic chemopreventive agent, restores expression of ARHI and may be an important dietary therapeutic agent for treating prostate cancer.",
author = "Yi Chen and {Saif Zaman}, Mohd and Guoren Deng and Shahana Majid and Shranjot Saini and Jan Liu and Yuichiro Tanaka and Rajvir Dahiya",
year = "2011",
month = "1",
day = "1",
doi = "10.1158/1940-6207.CAPR-10-0167",
language = "English (US)",
volume = "4",
pages = "76--86",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer

AU - Chen, Yi

AU - Saif Zaman, Mohd

AU - Deng, Guoren

AU - Majid, Shahana

AU - Saini, Shranjot

AU - Liu, Jan

AU - Tanaka, Yuichiro

AU - Dahiya, Rajvir

PY - 2011/1/1

Y1 - 2011/1/1

N2 - ARHI is an imprinted tumor suppressor gene and is downregulated in various malignancies. However, ARHI expression, function, and mechanisms of action in prostate cancer have not been reported. Here, we report that ARHI mRNA and protein levels were downregulated in prostate cancer tissues compared with adjacent normal tissues. Overexpression of ARHI inhibited cell proliferation, colony formation, invasion, and induced apoptosis. Further studies on a new mechanism of ARHI downregulation showed a significant inverse relationship between ARHI and miR-221 and 222, which were upregulated in prostate cancer cell lines. Transfection of miR-221 and 222 inhibitors into PC-3 cells caused a significant induction of ARHI expression. A direct interaction of miR-221 or 222 with a target site on the 3′UTR of ARHI was confirmed by a dual luciferase pMIR-REPORT assay. Finally, we also found that genistein upregulates ARHI by downregulating miR-221 and 222 in PC-3 cells. In conclusion, ARHI is a tumor suppressor gene downregulated in prostate cancer, and overexpression of ARHI can inhibit cell proliferation, colony formation, and invasion. This study demonstrates for the first time that prostate cancer cells have decreased level of ARHI which could be caused by direct targeting of 3′UTR of ARHI by miR221/222. Genistein, a potential nontoxic chemopreventive agent, restores expression of ARHI and may be an important dietary therapeutic agent for treating prostate cancer.

AB - ARHI is an imprinted tumor suppressor gene and is downregulated in various malignancies. However, ARHI expression, function, and mechanisms of action in prostate cancer have not been reported. Here, we report that ARHI mRNA and protein levels were downregulated in prostate cancer tissues compared with adjacent normal tissues. Overexpression of ARHI inhibited cell proliferation, colony formation, invasion, and induced apoptosis. Further studies on a new mechanism of ARHI downregulation showed a significant inverse relationship between ARHI and miR-221 and 222, which were upregulated in prostate cancer cell lines. Transfection of miR-221 and 222 inhibitors into PC-3 cells caused a significant induction of ARHI expression. A direct interaction of miR-221 or 222 with a target site on the 3′UTR of ARHI was confirmed by a dual luciferase pMIR-REPORT assay. Finally, we also found that genistein upregulates ARHI by downregulating miR-221 and 222 in PC-3 cells. In conclusion, ARHI is a tumor suppressor gene downregulated in prostate cancer, and overexpression of ARHI can inhibit cell proliferation, colony formation, and invasion. This study demonstrates for the first time that prostate cancer cells have decreased level of ARHI which could be caused by direct targeting of 3′UTR of ARHI by miR221/222. Genistein, a potential nontoxic chemopreventive agent, restores expression of ARHI and may be an important dietary therapeutic agent for treating prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=78650842745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650842745&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-10-0167

DO - 10.1158/1940-6207.CAPR-10-0167

M3 - Article

C2 - 21071579

AN - SCOPUS:78650842745

VL - 4

SP - 76

EP - 86

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 1

ER -